Arkolith/Insider Trading/TCRT/Form 4

Postma Robert W

DirectorAlaunos Therapeutics, Inc. (TCRT) · full profile →Form 4 · filed Apr 15, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 13, 2025Grant(A)21K$2.92$61K29K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 11, 2025Buy(P)500$2.76$1K500

Transaction Codes

A
Grant / award
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-054436) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML